Search
Menu
Home
HTB
2011
July
14
14 July 2011
Contents
Editorial
Introduction and executive summary
Acknowledgments
Dedication
Pipeline report
HIV point of care diagnostics pipeline
The tuberculosis treatment pipeline
The hepatitis C treatment pipeline
The paediatric antiretroviral pipeline
The antiretroviral pipeline
The tuberculosis diagnostic pipeline
The tuberculosis vaccine pipeline
Patents and the pipeline: is access under threat?
HIV prevention and transmission
Preventive technologies, immune-based and gene therapies, and research towards a cure
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate